TD Asset Management
WVE icon

TD Asset Management’s Wave Life Sciences WVE Stock Holding History

TD Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Buy
338,826
+86,666
+34% +$1.13M ﹤0.01% 923
2025
Q4 		$4.29M Buy
252,160
+109,752
+77% +$1.12M ﹤0.01% 827
2025
Q3 		$1.04M Sell
142,408
-37,200
-21% -$301K ﹤0.01% 1084
2025
Q2 		$1.17M Buy
179,608
+25,200
+16% +$166K ﹤0.01% 1040
2025
Q1 		$1.25M Sell
154,408
-161,798
-51% -$1.77M ﹤0.01% 1047
2024
Q4 		$3.91M Buy
316,206
+64,400
+26% +$860K ﹤0.01% 842
2024
Q3 		$2.09M Buy
251,806
+67,860
+37% +$406K ﹤0.01% 1021
2024
Q2 		$918K Sell
183,946
-68,000
-27% -$388K ﹤0.01% 1178
2024
Q1 		$1.55M Buy
251,946
+46,200
+22% +$231K ﹤0.01% 1084
2023
Q4 		$1.04M Buy
205,746
+43,054
+26% +$230K ﹤0.01% 1175
2023
Q3 		$935K Buy
+162,692
New +$743K ﹤0.01% 1160
2021
Q1 		– Sell
-51,234
Closed -$403K – 1550
2020
Q4 		$403K Buy
+51,234
New +$430K ﹤0.01% 1359

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

TD Asset Management's WVE Position: Q1 2026 in Review

TD Asset Management increased its Wave Life Sciences (WVE) stake by 34% in Q1 2026, buying an estimated $1.13M and bringing the position to 338,826 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #923.

TD Asset Management first reported a position in WVE in Q4 2020 and has held it in 12 quarters since. The position peaked at $4.29M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • TD Asset Management held 338,826 shares of Wave Life Sciences worth $2.46M as of Q1 2026.
  • TD Asset Management bought 86,666 Wave Life Sciences shares in Q1 2026, an estimated $1.13M.
  • Wave Life Sciences made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #923 holding.
  • TD Asset Management first reported a position in Wave Life Sciences in Q4 2020 and has held it in 12 quarters since.
  • TD Asset Management's Wave Life Sciences position peaked at $4.29M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.